Cargando…

Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library

Botulinum toxins (BoNTs) are among the most toxic substances on earth, with serotype A toxin being the most toxic substance known. They are responsible for human botulism, a disease characterized by flaccid muscle paralysis that occurs naturally through food poisoning or the colonization of the gast...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miethe, Sebastian, Rasetti-Escargueil, Christine, Liu, Yvonne, Chahboun, Siham, Pelat, Thibaut, Avril, Arnaud, Frenzel, Andrè, Schirrmann, Thomas, Thullier, Philippe, Sesardic, Dorothea, Hust, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2014
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984333/ https://www.ncbi.nlm.nih.gov/pubmed/24492304 http://dx.doi.org/10.4161/mabs.27773

Ejemplares similares

Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E
por: Miethe, Sebastian, et al.
Publicado: (2015)

Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B
por: Rasetti-Escargueil, Christine, et al.
Publicado: (2015)

Isolation of nanomolar scFvs of non-human primate origin, cross-neutralizing botulinum neurotoxins A(1) and A(2) by targeting their heavy chain
por: Avril, Arnaud, et al.
Publicado: (2015)

Isolation of a nanomolar scFv inhibiting the endopeptidase activity of botulinum toxin A, by single-round panning of an immune phage-displayed library of macaque origin
por: Chahboun, Siham, et al.
Publicado: (2011)

Development of Germline-Humanized Antibodies Neutralizing Botulinum Neurotoxin A and B
por: Miethe, Sebastian, et al.
Publicado: (2016)

Neutralization of Botulinum Neurotoxin Type E by a Humanized Antibody
por: Derman, Yağmur, et al.
Publicado: (2016)

The European AntibotABE Framework Program and Its Update: Development of Innovative Botulinum Antibodies
por: Rasetti-Escargueil, Christine, et al.
Publicado: (2017)

Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity
por: Pelat, Thibaut, et al.
Publicado: (2009)

Isolation and Characterisation of a Human-Like Antibody Fragment (scFv) That Inactivates VEEV In Vitro and In Vivo
por: Rülker, Torsten, et al.
Publicado: (2012)

Recent Developments in Botulinum Neurotoxins Detection
por: Rasetti-Escargueil, Christine, et al.
Publicado: (2022)

Engineering Botulinum Neurotoxins for Enhanced Therapeutic Applications and Vaccine Development
por: Rasetti-Escargueil, Christine, et al.
Publicado: (2020)

Targeting scFv-Fc-scTRAIL fusion proteins to tumor cells
por: Hutt, Meike, et al.
Publicado: (2018)

Is it Possible to Accurately Determine Content of Botulinum Neurotoxin Type A in Drug Products?
por: Sesardic, Dorothea
Publicado: (2012)

Human-like antibodies neutralizing Western equine encephalitis virus
por: Hülseweh, Birgit, et al.
Publicado: (2014)

Cell-free eukaryotic systems for the production, engineering, and modification of scFv antibody fragments
por: Stech, Marlitt, et al.
Publicado: (2014)

Identification of Potent CD19 scFv for CAR T Cells through scFv Screening with NK/T-Cell Line
por: Kang, Chung Hyo, et al.
Publicado: (2020)

Targeting CEA in Pancreas Cancer Xenografts with a Mutated scFv-Fc Antibody Fragment
por: Girgis, Mark D, et al.
Publicado: (2011)

Cre-mediated cellular modification for establishing producer CHO cells of recombinant scFv-Fc
por: Kawabe, Yoshinori, et al.
Publicado: (2015)

scFv Antibody: Principles and Clinical Application
por: Ahmad, Zuhaida Asra, et al.
Publicado: (2012)

Tetanus Neurotoxin Neutralizing Antibodies Screened from a Human Immune scFv Antibody Phage Display Library
por: Wang, Han, et al.
Publicado: (2016)

A Cell Line for Detection of Botulinum Neurotoxin Type B
por: Rust, Aleksander, et al.
Publicado: (2017)

Nonspecificity in a nonimmune human scFv repertoire
por: Kelly, Ryan L., et al.
Publicado: (2017)

“Stapling” scFv for multispecific biotherapeutics of superior properties
por: Boucher, Lauren E., et al.
Publicado: (2023)

Characterization of an In Vivo Neutralizing Anti-Vaccinia Virus D8 Single-Chain Fragment Variable (scFv) from a Human Anti-Vaccinia Virus-Specific Recombinant Library
por: Diesterbeck, Ulrike S., et al.
Publicado: (2021)

Isolation and characterization of human anti-CD20 single-chain variable fragment (scFv) from a Naive human scFv library
por: Shams, Nasir, et al.
Publicado: (2022)

Preclinical Evaluation and Dosimetry of [(111)In]CHX-DTPA-scFv78-Fc Targeting Endosialin/Tumor Endothelial Marker 1 (TEM1)
por: Cicone, Francesco, et al.
Publicado: (2020)

Structural differences of amyloid-β fibrils revealed by antibodies from phage display
por: Droste, Patrick, et al.
Publicado: (2015)

Ophiophagus hannah Venom: Proteome, Components Bound by Naja kaouthia Antivenin and Neutralization by N. kaouthia Neurotoxin-Specific Human ScFv
por: Danpaiboon, Witchuda, et al.
Publicado: (2014)

Recommended Immunological Strategies to Screen for Botulinum Neurotoxin-Containing Samples
por: Simon, Stéphanie, et al.
Publicado: (2015)

Generation of Recombinant Antibodies Against Toxins and Viruses by Phage Display for Diagnostics and Therapy
por: Unkauf, Tobias, et al.
Publicado: (2016)

Development of a SARS-CoV-2-specific biosensor for antigen detection using scFv-Fc fusion proteins
por: Kim, Hye-Yeon, et al.
Publicado: (2021)

The effects of N-terminal insertion into VSV-G of an scFv peptide
por: Dreja, Hanna, et al.
Publicado: (2006)

Empowering scFv with effector cell functions for improved anticancer therapeutics
por: Zhang, Hongtao
Publicado: (2013)

Integrating scFv into xMAP Assays for the Detection of Marine Toxins
por: Shriver-Lake, Lisa C., et al.
Publicado: (2016)

The Four-State Equilibrium Unfolding of a scFv Antibody Fragment
por: Pedroso, Idolka, et al.
Publicado: (2002)

Humanization and directed evolution of the selenium-containing scFv phage abzyme
por: Xu, Yan, et al.
Publicado: (2018)

Engineered Human Monoclonal scFv to Receptor Binding Domain of Ebolavirus
por: Densumite, Jaslan, et al.
Publicado: (2021)

Functional Characterization of Two scFv-Fc Antibodies from an HIV Controller Selected on Soluble HIV-1 Env Complexes: A Neutralizing V3- and a Trimer-Specific gp41 Antibody
por: Trott, Maria, et al.
Publicado: (2014)

Site-specific Conjugation of 6 DOTA Chelators to a CA19-9-targeting scFv-Fc Antibody for Imaging and Therapy
por: Chen, Li-An, et al.
Publicado: (2023)

Antibodies and Vaccines against Botulinum Toxins: Available Measures and Novel Approaches
por: Rasetti-Escargueil, Christine, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_h9vb804sufrd2m50s7betdk4q7